165 related articles for article (PubMed ID: 31323301)
21. Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study.
Liao YH; Hsu RJ; Wang TH; Wu CT; Huang SY; Hsu CY; Su YC; Hsu WL; Liu DW
BMC Gastroenterol; 2020 Jan; 20(1):6. PubMed ID: 31918672
[TBL] [Abstract][Full Text] [Related]
22. Comparative Transcriptomics Analysis for Gene Mining and Identification of a Cinnamyl Alcohol Dehydrogenase Involved in Methyleugenol Biosynthesis from
Liu J; Xu C; Zhang H; Liu F; Ma D; Liu Z
Molecules; 2018 Dec; 23(12):. PubMed ID: 30513938
[No Abstract] [Full Text] [Related]
23. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B and C viruses in the etiology of hepatocellular carcinoma; a study in Greece using third-generation assays.
Kuper HE; Tzonou A; Kaklamani E; Hadziyannis S; Tasopoulos N; Lagiou P; Trichopoulos D; Stuver S
Cancer Causes Control; 2000 Feb; 11(2):171-5. PubMed ID: 10710202
[TBL] [Abstract][Full Text] [Related]
25. Fumigant Toxicity and Oviposition Deterrent Activity of Volatile Constituents from Asari Radix et Rhizoma against Phthorimaea operculella (Lepidoptera: Gelechiidae).
Wu M; Xiong Y; Han R; Dong W; Xiao C
J Insect Sci; 2020 Nov; 20(6):. PubMed ID: 33306098
[TBL] [Abstract][Full Text] [Related]
26. Comparison of clinical manifestations and outcomes between hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma: analysis of a nationwide cohort.
Sinn DH; Gwak GY; Cho J; Paik SW; Yoo BC
PLoS One; 2014; 9(11):e112184. PubMed ID: 25372403
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of HBV and HCV infection in Japanese patients with hepatocellular carcinoma.
Suga M; Senota A; Arima K; Kodama T; Ikuta S; Sakamoto H; Ohe Y; Sugai S; Yachi A
Hepatogastroenterology; 1994 Oct; 41(5):438-41. PubMed ID: 7531667
[TBL] [Abstract][Full Text] [Related]
28. Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease.
Nalpas B; Driss F; Pol S; Hamelin B; Housset C; Brechot C; Berthelot P
J Hepatol; 1991 Jan; 12(1):70-4. PubMed ID: 1848875
[TBL] [Abstract][Full Text] [Related]
29. Neither diabetes mellitus nor overweight is a risk factor for hepatocellular carcinoma in a dual HBV and HCV endemic area: community cross-sectional and case-control studies.
Tung HD; Wang JH; Tseng PL; Hung CH; Kee KM; Chen CH; Chang KC; Lee CM; Changchien CS; Chen YD; Lu SN
Am J Gastroenterol; 2010 Mar; 105(3):624-31. PubMed ID: 20051944
[TBL] [Abstract][Full Text] [Related]
30. Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection.
Tsan YT; Lee CH; Wang JD; Chen PC
J Clin Oncol; 2012 Feb; 30(6):623-30. PubMed ID: 22271485
[TBL] [Abstract][Full Text] [Related]
31. Does hepatitis C virus infection contribute to hepatocellular carcinoma in Hong Kong?
Leung NW; Tam JS; Lai JY; Leung TW; Lau WY; Shiu W; Li AK
Cancer; 1992 Jul; 70(1):40-4. PubMed ID: 1318777
[TBL] [Abstract][Full Text] [Related]
32. Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus-positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus.
Tanaka H; Tsukuma H; Yamano H; Oshima A; Shibata H
Int J Cancer; 2004 Dec; 112(6):1075-80. PubMed ID: 15386355
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study.
Donato F; Tagger A; Chiesa R; Ribero ML; Tomasoni V; Fasola M; Gelatti U; Portera G; Boffetta P; Nardi G
Hepatology; 1997 Sep; 26(3):579-84. PubMed ID: 9303486
[TBL] [Abstract][Full Text] [Related]
34. A comparison of patients with hepatitis B- or hepatitis C-based advanced-stage hepatocellular carcinoma.
Carr BI; Guerra V; Steel JL; Lu SN
Semin Oncol; 2015 Apr; 42(2):309-15. PubMed ID: 25843735
[TBL] [Abstract][Full Text] [Related]
35. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
36. Comparison of viral hepatitis-associated hepatocellular carcinoma due to HBV and HCV - cohort from liver clinics in Pakistan.
Munaf A; Memon MS; Kumar P; Ahmed S; Kumar MB
Asian Pac J Cancer Prev; 2014; 15(18):7563-7. PubMed ID: 25292029
[TBL] [Abstract][Full Text] [Related]
37. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
38. Hospital- and community-based screenings for hepatocellular carcinoma in Taiwan.
Kee KM; Lu SN
Oncology; 2011; 81 Suppl 1():36-40. PubMed ID: 22212934
[TBL] [Abstract][Full Text] [Related]
39. Diabetes mellitus, metabolic syndrome and obesity are not significant risk factors for hepatocellular carcinoma in an HBV- and HCV-endemic area of Southern Taiwan.
Chen CT; Chen JY; Wang JH; Chang KC; Tseng PL; Kee KM; Chen PF; Tsai LS; Chen SC; Lin SC; Lu SN
Kaohsiung J Med Sci; 2013 Aug; 29(8):451-9. PubMed ID: 23906236
[TBL] [Abstract][Full Text] [Related]
40. Trends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000-2014).
Waziry R; Grebely J; Amin J; Alavi M; Hajarizadeh B; George J; Matthews GV; Law M; Dore GJ
J Hepatol; 2016 Dec; 65(6):1086-1093. PubMed ID: 27569777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
